ASK: "THE LAST DON" OF MOMENTUM TRADES Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ASK: "THE LAST DON" OF MOMENTUM TRADES

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MoneyMade who wrote (509)	3/25/1999 5:07:00 PM
From: MoneyMade	Read Replies (1) of 15987

More great news from DRMD!! Somebody stop me! The conference call (1-888-266-2081. Password: 1419338, for replay) said they had a letter of intent signed with a Fortune 200 company, for marketing of Cenestin - and that the agreement would be finalized in a few days. Looking at the Fortune 500 list, I see 4 pharmaceutical firms in the Fortune 200 list: Eli Lily, Warner-Lambert, Abbott and Pfizer. I wonder which firm it is. Conference call also said Premarin has 70% of the estrogen market; that market is currently $2 billion a year and growing at 15% annually. RePost from Yahoo: marketing agreement by: nicegirl99 (F/Planet Earth) 5686 of 5686 ______________________________________________________________________ Mr. MoneyMade Savvy investor extraordinair

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next